Beginning a New Decade at Pacific Neuroscience Institute
by Daniel F. Kelly
Dr. Daniel F. Kelly’s article about the future of Pacific Neuroscience Institute was featured in the Santa Monica Star. See the full article below and find out what PNI is looking forward to as we enter a new decade.
Plans for 2020 and Beyond
It feels like science fiction but here we are at the year 2020. At Pacific Neuroscience Institute we are ready for the new decade with personalized care for all our patients.
Over the past year there have been exciting developments at the Pacific Brain Health Center (PBHC) for middle aged and older adults. As human longevity increases, it is important that we protect our most important asset, the brain.
What’s Happening at the Pacific Brain Health Center
- The PREVENTION clinical trial is well underway assessing the impact of combined physical and cognitive exercise for people who have early symptoms of Alzheimer’s disease.
- The Cognitive Fitness (CogFit) Studio completed a pilot beta-test class and is available to PREVENTION clinical trial participants as well as patients seeking clinical care at the PBHC for brain health and memory fitness.
New Addiction Medicine Services at PBHC this Spring
40 million Americans aged 12 or older, that’s 1 in 7, have a substance problem. To help, we will be unveiling our Addiction Medicine services at PBHC this Spring for the assessment, treatment and prevention of addiction and substance use issues including problems with drugs, alcohol and prescription medications across all age groups.
New Cancer Psychiatry (Psycho-oncology) Services
No one should have to go through cancer alone. Our new cancer psychiatry (psycho-oncology) services at Providence Saint John’s Health Center focus on patients and their loved ones, providing support and resources as they are confronted with a cancer diagnosis and its treatment.
PNI’s Ongoing Commitment To Care
Taking care of the challenging diseases of the brain is our top priority. With leading-edge standard therapies as well as novel clinical trials and protocols, we have been able to care for patients with conditions such as stroke and brain trauma, Alzheimer’s disease, Parkinson’s disease, pituitary disorders, and brain tumor. In many cases, our multidisciplinary teams are able to see our patients in a single visit.
Adapted from original article: Santa Monica Star, January 2020, page 2
About the Author
Daniel F. Kelly
Daniel F. Kelly, MD, is the Director of the Pacific Brain Tumor and Pituitary Disorders Centers at Providence Saint John’s Health Center in Santa Monica, CA. Considered to be one of the top neurosurgeons in the U.S., Dr. Kelly is internationally recognized in the field of minimally invasive keyhole surgery for brain, pituitary and skull base tumors. He continues to focus his efforts on advancing innovative treatments for patients, providing fellowship training in minimally invasive neurosurgery, and patient education and support.
Last updated: March 23rd, 2020